Overview
- The Series A was co-led by Cencora Ventures and Optum Ventures, with participation from Oncology Ventures, Z21 Ventures, and John Simon via Ventureforgood.
- Risa’s platform connects to electronic medical records, payer portals, and benefits systems to automate benefits verification and prior authorization using AI agents.
- The company says it is live at eight oncology practices with about 15 additional sites under contract and is processing thousands of cancer cases each day.
- Company-reported outcomes include major cuts in administrative staff time, denials reduced by up to 40%, and first-pass authorization approval rates approaching 98%.
- New funding will expand the go-to-market team, deepen existing deployments, and extend the operating layer into specialty pharmacy workflows while keeping focus on oncology.